Millendo Therapeutics, Inc. (MLND) Social Stream
Millendo Therapeutics Inc (MLND) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MLND.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 37 days, MLND's average price target has gone down $0.
Over the past 81 days, MLND's average upside potential has been 1.2%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MLND Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- MLND has a lower variance in analysts' estimates than almost 100% of all US stocks.
- MLND has a greater average analyst price target than 1.7% of Healthcare stocks.
- The number of analysts covering the stock of MLND is higher than 13.94% of Pharmaceutical Products stocks.
- MLND has a higher upside potential (average analyst target price relative to current price) than 83.79% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Millendo Therapeutics Inc are TLGT, LHDX and LFVN.
What is the outlook for MLND? Use POWR Ratings for clearer insight into price direction.